| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 19:04:39 UTC |
|---|
| Updated at | 2024-09-10 19:04:39 UTC |
|---|
| NP-MRD ID | NP0334597 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | NG,NG-Dimethyl-L-arginine |
|---|
| Description | Asymmetric dimethylarginine, also known as N(g),N(g)-dimethylarginine or ADMA, belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Asymmetric dimethylarginine is a very strong basic compound (based on its pKa). Asymmetric dimethylarginine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, Asymmetric dimethylarginine is found, on average, in the highest concentration within a few different foods, such as wheats, barley, and oats and in a lower concentration in turnips, saskatoon berries, and spinachs. Asymmetric dimethylarginine has also been detected, but not quantified in, pulses. This could make asymmetric dimethylarginine a potential biomarker for the consumption of these foods. Asymmetric dimethylarginine is a potentially toxic compound. NG,NG-Dimethyl-L-arginine was first documented in 1999 (PMID: 10218738). A L-arginine derivative having two methyl groups both attached to the primary amino moiety of the guanidino group (PMID: 16119611) (PMID: 15568284) (PMID: 15558588). |
|---|
| Structure | N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| ADMA | ChEBI | | Guanidino-N,N-dimethylarginine | ChEBI | | N,N-Dimethylarginine | ChEBI | | N(5)-((Dimethylamino)iminomethyl)-L-ornithine | ChEBI | | NG,NG-Dimethyl-L-arginine | ChEBI | | N(g),N(g)-Dimethylarginine | ChEBI | | N(g)-Dimethylarginine | ChEBI | | N(g1),N(g1)-Dimethylarginine | ChEBI | | Nomega,nomega-dimethyl-L-arginine | Kegg | | 2-Amino-5-(amino-dimethylamino-methylidene)amino-pentanoate | HMDB | | 2-Amino-5-(amino-dimethylamino-methylidene)amino-pentanoic acid | HMDB | | Dimethyl-L-arginine | HMDB | | N(Omega),N(omega)-dimethyl-L-arginine | HMDB | | NG,NG-Dimethylarginine | HMDB | | NG-Dimethylarginine | HMDB | | Nomega,nomega'-dimethyl-L-arginine | HMDB | | Asymmetric dimethylarginine | ChEBI |
|
|---|
| Chemical Formula | C8H18N4O2 |
|---|
| Average Mass | 202.2541 Da |
|---|
| Monoisotopic Mass | 202.14298 Da |
|---|
| IUPAC Name | (2S)-2-amino-5-[(E)-[amino(dimethylamino)methylidene]amino]pentanoic acid |
|---|
| Traditional Name | asymmetric dimethylarginine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1 |
|---|
| InChI Key | YDGMGEXADBMOMJ-LURJTMIESA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as arginine and derivatives. Arginine and derivatives are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Arginine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Arginine or derivatives
- Alpha-amino acid
- L-alpha-amino acid
- Fatty acid
- Guanidine
- Amino acid
- Carboximidamide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Imine
- Carbonyl group
- Amine
- Organic nitrogen compound
- Organic oxide
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC: Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol. 1999 Apr;33(4):652-8. [PubMed:10218738 ]
- Watanabe T, Kato S, Sato K, Nagata K: Nitric oxide regulation system in degenerative lumbar disease. Kurume Med J. 2005;52(1-2):39-47. doi: 10.2739/kurumemedj.52.39. [PubMed:16119611 ]
- Nijveldt RJ, Teerlink T, Siroen MP, van der Hoven B, Prins HA, Wiezer MJ, Meijer C, van der Sijp JR, Cuesta MA, Meijer S, van Leeuwen PA: Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy. JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):382-7. doi: 10.1177/0148607104028006382. [PubMed:15568284 ]
- Siroen MP, Warle MC, Teerlink T, Nijveldt RJ, Kuipers EJ, Metselaar HJ, Tilanus HW, Kuik DJ, van der Sijp JR, Meijer S, van der Hoven B, van Leeuwen PA: The transplanted liver graft is capable of clearing asymmetric dimethylarginine. Liver Transpl. 2004 Dec;10(12):1524-30. doi: 10.1002/lt.20286. [PubMed:15558588 ]
|
|---|